Clinical trial
Sorafenib Long Term Extension Program
NCT00625378 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sorafenib Long Term Extension Program
- Lead sponsor
- Bayer
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 21, 2007
- Completion date
- September 24, 2021
- Enrollment
- 206 (actual)
- Sites
- 74
Conditions
As the registry lists them; a condition with its own page is linked.